Kush Parmar, Director, 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 568,140 shares at $20.00 ($5.0M) on 2021-11-02, disclosed to the SEC on 2021-11-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 318,140 | $0 | 0.0% |
| 2 | $20.00 | 250,000 | $5.0M | 100.0% |
| Total | $8.80 avg | 568,140 | $5.0M | 100% |
| Filing → |
| TRDA | SELL | 2025-11-18 | $3.5M | — | Filing → |
| TRDA | SELL | 2025-07-11 | $405K | — | Filing → |
| TRDA | SELL | 2025-07-01 | $1.6M | — | Filing → |